Rodney U. Anderson, MD FACS

Publications

• Safety and effectiveness of an internal pelvic myofascial trigger point wand for urologic chronic pelvic pain syndrome. Anderson R, Wise D, Sawyer T, Nathanson BH. Clin J Pain. 2011 Nov-Dec; 27 (9): 764-8
• 6-day intensive treatment protocol for refractory chronic prostatitis/chronic pelvic pain syndrome using myofascial release and paradoxical relaxation training. Anderson RU, Wise D, Sawyer T, Glowe P, Orenberg EK. J Urol. 2011; 185 (4): 1294-9
• Painful myofascial trigger points and pain sites in men with chronic prostatitis/chronic pelvic pain syndrome. Anderson RU, Sawyer T, Wise D, Morey A, Nathanson BH. J Urol. 2009; 182 (6): 2753-8
• Randomized multicenter feasibility trial of myofascial physical therapy for the treatment of urological chronic pelvic pain syndromes. FitzGerald MP, Anderson RU, Potts J, Payne CK, Peters KM, Clemens JQ, Kotarinos R, Fraser L, Cosby A, Fortman C, Neville C, Badillo S, Odabachian L, Sanfield A, O'Dougherty B, Halle-Podell R, Cen L, Chuai S, Landis JR, Mickelberg K, Barrell T, Kusek JW, Nyberg LM. J Urol. 2009; 182 (2): 570-80
• Stress induced hypothalamus-pituitary-adrenal axis responses and disturbances in psychological profiles in men with chronic prostatitis/chronic pelvic pain syndrome. Anderson RU, Orenberg EK, Morey A, Chavez N, Chan CA. J Urol. 2009; 182 (5): 2319-24
• Psychometric profiles and hypothalamic-pituitary-adrenal axis function in men with chronic prostatitis/chronic pelvic pain syndrome. Anderson RU, Orenberg EK, Chan CA, Morey A, Flores V. J Urol. 2008; 179 (3): 956-60
• Sexual dysfunction in men with chronic prostatitis/chronic pelvic pain syndrome: improvement after trigger point release and paradoxical relaxation training. Anderson RU, Wise D, Sawyer T, Chan CA. J Urol. 2006; 176 (4 Pt 1): 1534-8; discussion 1538-9
• Traditional therapy for chronic pelvic pain does not work: what do we do now? Anderson RU, Nat Clin Pract Urol. 2006; 3 (3): 145-56
• Integration of myofascial trigger point release and paradoxical relaxation training treatment of chronic pelvic pain in men. Anderson RU, Wise D, Sawyer T, Chan C. J Urol. 2005; 174 (1): 155-60
• Once daily controlled versus immediate release oxybutynin chloride for urge urinary incontinence. OROS Oxybutynin Study Group. Anderson RU, Mobley D, Blank B, Saltzstein D, Susset J, Brown JS. J Urol. 1999; 161 (6): 1809-12
• Urodynamic patterns after acute spinal cord injury: association with bladder trabeculation in male patients. Anderson RU, J Urol. 1983; 129 (4): 777-9
• Chronic prostatitis/chronic pelvic pain: Is there a psychosocial component? Anderson RU, Can Urol Assoc J. 2011; 5 (5): 333-4
• Pain: drug therapies for CP/CPPS: help or hype? Anderson RU, Nathanson BH. Nat Rev Urol. 2011; 8 (5): 236-7
• Effectiveness and tolerability of extended-release oxybutynin vs extended-release tolterodine in women with or without prior anticholinergic treatment for overactive bladder. Anderson RU, MacDiarmid S, Kell S, Barada JH, Serels S, Goldberg RP. Int Urogynecol J Pelvic Floor Dysfunct. 2006; 17 (5): 502-11
• Pharmacotherapy for neurogenic detrusor overactivity. Chancellor MB, Anderson RU, Boone TB. Am J Phys Med Rehabil. 2006; 85 (6): 536-45
• Efficacy and safety of extended release oxybutynin for the treatment of urge incontinence: an analysis of data from 3 flexible dosing studies. MacDiarmid SA, Anderson RU, Armstrong RB, Dmochowski RR. J Urol. 2005; 174 (4 Pt 1): 1301-5; discussion 1305
• Management of chronic prostatitis-chronic pelvic pain syndrome. Anderson RU, Urol Clin North Am. 2002; 29 (1): 235-9
• Management of lower urinary tract infections and cystitis. Anderson RU, Urol Clin North Am. 1999; 26 (4): 729-35, viii
• Detrusor-sphincter dyssynergia and vesico urethral reflux: management. Perkash I, Linsenmeyer TA, Bodner DR, Anderson RU. Spinal Cord. 1998; 36 (1): 2-5
• Mucinous adenocarcinoma of the renal pelvis in natives of India. Terris MK, Anderson RU. Urol Int. 1997; 58 (2): 121-3
• Treatment of complicated and uncomplicated urinary tract infections. Antibiotic Treatment of Urinary Tract Infections Anderson RU, Lippincott-Raven. 1996
• Medical therapy alone for the treatment of gas forming intrarenal abscess. Nickas ME, Reese JH, Anderson RU. J Urol. 1994; 151 (2): 398-400
• Voiding symptoms and bladder function following CVA: a prospective time course study Linsenmeyer TA, Anderson RU. NeuroRehab. 1994: 4 259-265
• Functional and urodynamic characteristics of an ileal neobladder. Iwakiri J, Gill H, Anderson R, Freiha F. J Urol. 1993; 149 (5): 1072-6
• Neurogenic bladder Anderson RU, Monographs in Urol.. 1992: 13 6
• Endoscopic urethroplasty: an improved technique. deVries CR, Anderson RU. J Urol. 1990; 143 (6): 1225-6
• Splenic abscess arising by direct extension from a perinephric abscess. Reese JH, Anderson RU, Friedland G. Urol Radiol. 1990; 12 (2): 91-3
• Treatment of experimental bladder cancer with hyperthermia and phase transition liposomes containing methotrexate. Bassett JB, Tacker JR, Anderson RU, Bostwick D. J Urol. 1988; 139 (3): 634-6
• Urologic complications in spinal cord-injured patients. Anderson RU, Urology. 1988; 32 (3 Suppl): 31-2